Event brochure for the upcoming Global Clinical Outsourcing Forum in May, Munich. With presentations, case studies and roundtable discussions from leading industry experts from Genzyme, Pfizer, Antisoma, Merck Serono and Grünenthal amoung others

1. Register and pay before 25th February 2011 to get
full access to the conference for just €549!
Presents the 2nd Annual *Terms Apply
Overall very valuable. Topics
interesting with valuable new
information that is appropriate &
relevant to what I am doing now.
Apo Pharma Inc.
Location:
THE WESTIn GRAnD, MUnICH
two Day conference:
17TH – 18TH MAy 2011
Pre-conference workshoP Day:
16TH MAy 2011
Driving Clinical Development and Speeding Time to Market through Effective Relationship
Management, Establishing CRO Accountability and Running Trials in BRIC Regions
Come away with fresh ideas on how to: Get exclusive insight from leading
industry experts including:
Develop your outsourcing strategy by exploring the various Dr Larry Blankstein, Senior Director of
Sponsor-CRO business models. Access over 5 case studies and Clinical Research, Genzyme
discussion focused sessions with pioneers from across the Dr Silvio Klimovsky, Head of Clinical
industry including Larry Blankstein, Genzyme Research Argentina and Uruguay, Pfizer
Uwe Schneider, Head of Global Sourcing
Establish CRO accountability and ensure your expectations Management & GCD Business Support,
are met by developing a clear RFP/RFI from the outset. Grünenthal
Hear first hand from Annika Ekelow, Outsourcing Manager, Corinne Pala, Vendor Relationship
Clinical Operations, Swedish Orphan Biovitrium Manager, Grünenthal
Hone your negotiation skills and understand the Pia Sauer Larsen, Outsourcing
Manager, LEO Pharma
importance of a thoroughly drafted contract in our series of
exclusive masterclasses. Discuss directly with Deirdre Hall, Hellen Boering, Director Clinical Research
Resources Management, Genzyme
Pfizer, Maria Agcaoili, Ascent Pharma Solutions and
Roger Joby, 1to1to1 Stig Moller Christensen, International
Planning & CRO Manager, ALK Abello
Explore the opportunities and complexities of running Christian Hucke, Head of Clincal
clinical trials in BRIC and emerging regions with expert insight Operations, Affimed Therapeutics
from Argentina, the Philippines and the wider Asia-Pacific Region Roger Joby, Managing Director, 1to1to1
Maximise the efficiency and quality of your clinical Yariv Hefez, Director Global Business
development programmes through good relationship Development and Alliance Management,
Merck Serono
management and trial oversight with expert case studies from
Larry Blankstein, Genzyme and Corinne Pala, Grünenthal Annika Ekelow, Outsourcing Manager,
Clinical Operations, Swedish Orphan
Devise risk sharing partnerships and evaluate the change Biovitrium
management implications. Get first hand insight from Mubera Krijezi, Senior Project Manager
Yariv Hefez, Director Global Business Development and Phase I Group, Actelion
Alliance Management, Merck Serono Mayur Trivedi, Senior Clinical QA
Auditor, Antisoma
Maria Acagoili, CEO and Founder Ascent
Pre-conference Workshop Day: Pharma Solutions (Formerly Director
Contracts and Outsourcing, Pfizer)
This is a unique opportunity to get in depth insight into the critical
factors for successful outsourcing and drug development. Take the Richard Pompe, Group R&D Purchasing
time to discuss and share ideas with leading experts in the field of clinical Director, Mylan
outsourcing, working in emerging markets and adopting the Deirdre Hall, Director, Global Team Lead
right relationship strategy for your organisation. Business Operations, Contracts
Workshop A: & Outsourcing, Pfizer
Optimising Clinical Development Emerging and Take Off Markets Anne Maria Ylisaari, Head of In and
Dr Silvio Klimovsky, Head of Clinical Research Argentina Outsourcing, Orion Pharma
and Uruguay, Pfizer
Dr Ashish Gawde, Head of Monitoring
Negotiation Masterclass & Site Management, India, Taiwan,
Roger Joby, Managing Director, 1to1to1 Indonesia and the Philippines, Bayer
W W W.G L O B A L C L I n I C A L O U T S O U R C I n G .C O M
MeDia
sPonsor: Partners:
+44 (0)20 7368 9300 +44 (0)20 7368 9301 www.globalclinicaloutsourcing.com enquire@iqpc.co.uk

2. PREconfEREncE WoRkshoP DAy Monday 16th May 2011
optimising your clinical Development and Patient recruitment through effective
negotiation, relationship Management and running trials in emerging Markets
workshoP a – 10.30 – 13.30
cAsE sTUDy
optimising clinical Development emerging and take off Markets
This hands-on workshop will enable participants to explore and understand the challenges and opportunities
associated with outsourcing clinical trials in Latin America.
There will be an interactive case study and hypothetical scenario session where participants will be able to work
together and share ideas before feeding back to the group.
You will walk away from this workshop with new ideas on:
• Regulatory and quality assessment in Latin America
• Evaluating potential hurdles and taking a preventative approach to avoid delays
• Developing a long term strategy in Latin America
Dr Silvio Klimovsky, Head of Clinical Research Argentina and Uruguay, Pfizer
negotiation Masterclass – 14.30 – 17.30
This masterclass will provide a practical approach to contract development and negotiation to ensure that
you get the best start to your working relationship. You will get first hand insight from the full spectrum of
participants from big pharma, small to medium sized biotech and the CRO perspective.
Roger Joby, Managing Director, 1to1to1
about your workshop Leader
Roger is a chartered scientist and a member of the Association for Project Management (APM) and has been
involved in the pharmaceutical industry for over 30 years. He has experience in Clinical Operations, Project
Management, Proposal Generation and third party contracts at all levels.
He has worked as an employee and more recently as a consultant for several Pharmaceutical Companies and
Clinical Research Organisations (CROs)
Roger also takes an active part in project management research and has published several papers on the role
of Earned Value Analysis in clinical research with a colleague Dr. David Bryde (Liverpool JM University).
In addition to Earned Value, Roger is also interested in Risk Analysis, Project Pricing, Forecasting and
Stakeholder analysis.
Why Attend?
Explore the latest strategies and approaches for Informative, examples from daily practice.
efficient outsourcing and clinical development. Medigene AG
Hear from a mix of pharma organisations of all
shapes and sizes and share strategies and
relationship management approaches.
I learned a lot at
A good mix of functional areas. For training this conference-the
purposes it has been enlightening. topics were interesting.
ONO Pharmaceutical UK Janssen
W W W.G L O B A L C L I n I C A L O U T S O U R C I n G .C O M
+44 (0)20 7368 9300 +44 (0)20 7368 9301 enquire@iqpc.co.uk

3. confEREncE DAy onE Tuesday 17th May 2011
08.15 registration and coffee Panellists:
09.00 Pharma iQ’s welcome and opening remarks from chairperson Dr silvio klimovsky, Head of Clinical Research
Uwe schneider, Head of Global Sourcing Management Argentina and Uruguay, Pfizer
& GCD Business Support, Grünenthal Maria agcaoili, CEO, Founder, ascent Pharma solutions
(Formerly Director, Contracts & Outsourcing, Pfizer)
Uncovering the opportunities and accessing new Populations Dr ashish Gawde, Head of Monitoring & Site Management
by running trials in emerging and take off Markets India, Taiwan, Indonesia and the Philippines, Bayer
09.10 keynote Presentation: evaluating the future trends in clinical 10.40 networking refreshment Break
Development in ‘Pharmerging’ and Latin american regions
11.10 sponsor spotlight session
cAsE sTUDy
• An overview of those regions experiencing a “take
off” path in the market growth/life cycle curve This session will be dedicated to a leading service provider
• Predicting and investigating the new challenges posed within the clinical field, offering you the opportunity to hear
• Tapping into local resources and populations first hand how the latest innovations can help you reach your
• Real life examples of trials run in Korea and Latin America drug development goals.
Dr silvio klimovsky, Head of Clinical Research, Developing optimal strategies for niche studies
Argentina and Uruguay, Pfizer and ensuring cost-efficiency
09.40 running clinical trials conducted in the asia-Pacific region 11.40 Understanding when and how to implement
• Key challenges and opportunities for running trials in insourcing solutions
emerging markets • In-sourcing vs. outsourcing - getting the right balance
cAsE sTUDy
• An overview of patient recruitment strategies • Saving time and money through recruiting external
and opportunities CRAs for multiple, smaller studies
• Enhancing trial efficiency through complete understanding • Developing recruitment strategies and accessing
of regulations and legislation local talent
• The impact of cultural awareness hellen Boering, Director Clinical Research Resources
Dr ashish Gawde, Head of Monitoring & Site Management Management, Genzyme
India, Taiwan, Indonesia and the Philippines, Bayer 12.10 speed networking – ‘young Guns and old hats‘
10.10 PaneL: successfully outsourcing to emerging Markets An opportunity to exchange ideas with other participants at
and take off regions different levels of experience to you. This session will be
As clinical development and outsourcing become truly divided based upon your experience in the outsourcing field
global, how are you maximising the opportunities of and will allow you to forge new contacts and get
emerging markets and developing relationships with a fresh perspective.
partners in these regions? you can put these questions and 12.40 networking Lunch
more to the panel in this interactive discussion about the
future of clinical outsourcing.
stream a: stream B:
addressing the needs of small and Medium sized organisations addressing the needs of Big Pharma and risk sharing Partnership
CHAIR: Uwe schneider, Head of Global Sourcing Management Development
& GCD Business Support, Grünenthal CHAIR: yariv hefez, Director Global Business Development and
Alliance Management, Merck serono
14.10 establishing optimum selection criteria to enhance the open Discussion session - a risky Business
cro selection Process Many big players in the pharma industry are consolidating down
• Matching the right CRO to your company and individual trial needs to one or two clinical research partners in order to drive cost
cAsE sTUDy
• Assessing the track record and capabilities of CROs containment and achieve economies of scale.
• Can we really maximise clinical development by working This session will allow you to discuss openly with peers as to
with a large CRO? the risks and opportunities and how to develop an outsourcing
• Setting realistic KPIs from the outset and ensuring these are met strategy to meet your company’s need and pipeline.
• Implementing pilot studies to directly assess several partners yariv hefez, Director Global Business Development and Alliance
simultaneously and taking a comparative approach Management, Merck serono
• Ensuring access to high quality CRAs
christian hucke, Head of Clinical Operations, affimed therapeutics
14.40 successful relationship Management strategies and successful relationship Management strategies and
Gauging efficiency Gauging efficiency
• Driving efficiency and trial success through close communication • Facilitating relationship management and communication
and relationship management with your trial manager through a reduced number of partners
• Setting realistic KPIs and ensuring your project team is on track • Setting realistic KPIs and ensuring your project team is on track
• Getting your voice heard throughout the partnership • Achieving cost savings from reduced sponsor oversight requirements
corinne Pala, Vendor Relationship Manager, Grünenthal Dr Larry Blankstein, Senior Director of Clinical Research, Genzyme
15.10 successful strategies for full outsourcing and establishing establishing an innovative operational risk sharing Partnership
cro accountability • Understanding the key drivers for the change to a new
• An overview of full vs. functional outsourcing innovative business model
cAsE sTUDy
cAsE sTUDy
• The role of RFP and contract negotiation in ensuring • An overview of the partnering process
expectations are met • The key changes needed in order to implement the new model
• Taking a collaborative approach to clinical development • Successfully implementing the change management plan
• Transferring accountability to your CRO for patient yariv hefez, Director Global Business Development and Alliance
recruitment, site selection etc. Management, Merck serono
annika ekelow, Outsourcing Manager, Clinical Operations,
swedish orphan Biovitrium
15.40 networking refreshment Break
16.10 PaneL: assessing the Varying strategies of Different organisations according to size - what can we Learn from each other?
This session brings together the findings from the afternoon streams to compare and contrast the different approaches of big and small
pharma. A perfect opportunity to share best practices and find out what your peers are doing to drive clinical development.
facilitators:
Uwe schneider, Head of Global Sourcing Management & GCD Business Support, Grünenthal
corrine Pala, Vendor Relationship Manager, Grünenthal
Pia sauer Larsen, Outsourcing Manager, Leo Pharma
christian hucke, Head of Clincal Operations, affimed therapeutics
yariv hefez, Director Global Business Development and Alliance Management, Merck serono
17.00 closing remarks from chairperson and end of Day one
17.10 networking Drinks reception
+44 (0)20 7368 9300 +44 (0)20 7368 9301 enquire@iqpc.co.uk

4. confEREncE DAy TWo Wednesday 18th May 2011
08.15 registration and coffee 14.20 PaneL: how we created the Perfect Partnership
This interactive session brings you a real life, working
09.00 Pharma iQ’s welcome and opening remarks example of how a sponsor and CRO established the perfect
from chairperson deal and partnership from scratch. Engage directly with
those who have overcome the challenges and are on their way
ensuring appropriate Quality standards and GcP to successful drug development.
for clinical trials worldwide Pia sauer Larsen, Outsourcing Manager, Leo Pharma
yariv hefez, Director Global Business Development and
09.10 Maintaining Quality and GcP standards through
Alliance Management, Merck serono
effective trial oversight
richard Pompe, Group R&D Purchasing Director, Mylan
cAsE sTUDy
• The importance of trial oversight to ensure compliance
• Understanding GCP levels in emerging markets and 14.50 Breakout roundtable Discussions
strategies to ensure high standards Participants will be able to choose one of the roundtables
• Our approach: how we monitor trials in various regions outlined below and spend 1hour discussing the points.
Mayur trivedi, Senior Clinical QA Auditor, antisoma
a) functional vs. full outsourcing - evaluating the
Perfecting contract Development and negotiation Best approach for your company
strategies in a competitive environment Explore alternative approaches to outsourcing and the pros
and cons of functional and full outsourcing strategies. This is
09.40 interactiVe workshoP session
a perfect opportunity to share, benchmark and discuss the
the contract’s role in an outsourcing relationship
challenges and solutions with your peers.
This session aims to provide better understanding of the
Pia sauer Larsen, Outsourcing Manager, Leo Pharma
importance of a well-drafted contract to a successful
outsourcing relationship. The speakers will impart B) ensuring optimum Patient recruitment through
approaches and techniques during contract development effective contract negotiation and setting Milestones
that will assist in managing the outsourcing engagement This session will address the challenges of patient
throughout the project and there will be an open discussion recruitment and retention and strategies to overcome this in
session for a full 20 minutes following the presentation - find a bid to speed trials and time to market. There will be an
out all you need to know from the experts! emphasis on setting milestones and KPIs during
LearninG oBJectiVes: contract development.
• Identify the value of a well-written contract to an stig Moller christensen, International Planning
outsourcing relationship. & CRO Manager, aLk abello
• Develop familiarity with approaches and techniques in
developing an outsourcing contract. c) effective approaches to Measuring Performance
• Develop skills to utilise the contract in managing Management
an outsourcing relationship. Keeping on track with performance and measuring
co-facilitators: milestones will be addressed in this session, where you can
Maria agcaoili, CEO, Founder, ascent Pharma solutions explore the necessary steps to achieve a successful study
(Formerly Director, Contracts & Outsourcing, Pfizer) that gets results on time. you can get expert insight into
Deirdre hall, Director, Global Team Lead Business setting KPIs and how to minimise the impact of problems by
Operations, Contracts & Outsourcing, Pfizer spotting them early on.
christian hucke, Head of Clinical Operations,
11.00 networking refreshment Break affimed therapeutics
Guaranteeing success and cost effective clinical 15.50 avoiding Mistakes in cro selection
Development through effective relationship Management • Understanding the fundamentals of building and
maintaining successful partnerships
11.30 relationship Management strategies
• Predicting and resolving common sources of conflict
• Assessing the effectiveness of micromanagement over a
• Evaluating strategies to overcome these issues
less formal approach
anne Maria ylisaari, Head of In and Outsourcing,
• Improving productivity and avoiding delays through
orion Pharma
good communication
• Maintaining quality and ensuring GCP through 16.20 closing remarks from chairperson and end of Day two
comprehensive trial oversight
Mubera krijezi, Senior Project Manager Phase I Group,
actelion
Who will attend?
12.00 old hats, young Guns - Part two
The follow up to yesterday’s introduction, a chance to discuss Directors, senior managers and managers within pharmaceuti-
what you’ve gained from the experience and how you can cal manufacturers, biotech, CROs and academic institutes with
apply that to what’s going on in your organisation responsibility for:
• Outsourcing
12.30 sPonsor sPotLiGht session • Clinical Development
This session will be dedicated to a leading service provider • Clinical Operations
within the clinical field, offering you the opportunity to hear • Vendor Relationship Management
first hand how the latest innovations can help you reach your • Contract Management
drug development goals. • Alliance Management
13.00 networking Lunch
Overall very valuable. Topics interesting with valuable new information
that is appropriate & relevant to what I am doing now.
Apo Pharma Inc.
W W W.G L O B A L C L I n I C A L O U T S O U R C I n G .C O M
+44 (0)20 7368 9300 +44 (0)20 7368 9301 enquire@iqpc.co.uk

5. sPonsoRs AnD ExhibiToRs
MAxiMisE yoUR invoLvEMEnT:
sPonsoRshiP AnD ExhibiTion
oPPoRTUniTiEs
Pharma IQ’s Global Clinical Outsourcing Forum is the only event
Web: www.pharma-iq.com
that provides dedicated streams to separately address the different Become a member of Pharma IQ and receive complimentary access
needs and strategies of big pharma and of small to mid sized pharma/ to resources that will keep you at the forefront of industry change.
biotech companies. However, as budgets tighten across the globe, You will receive access to our growing library of multi-media
the industry is looking for the best approach to speed up clinical presentations from industry leaders, an email newsletter updating
development, get first time approval and ensure their drug reaches you on new content that has been added, free aggregated news feed
the market first. from over 1000 global news sources tracking your industry and special
member only discounts on events.
The conference is attended by senior officials and decision-makers
from the outsourcing, clinical and contract management fields,
bringing together buyers and suppliers together in one place.
Focused and high-level, the event will be an excellent platform
Media Partners
to initiate new business relationships. With tailored networking, The International Chamber of Commerce’s Business action to stop
counterfeiting and Piracy (BascaP) initiative unites the global business
sponsors can achieve the face-to-face contact that overcrowded community to more efficiently identify and address intellectual property
right (IPR) issues and petition for greater commitment by local, national
trade shows cannot deliver. and international officials in the enforcement and protection of
intellectual property. By delivering compelling messages from corporate
Exhibiting and sponsorship options are extensive and packages executives across industries, BASCAP underscores the severity of the
problem and compels governments and media to take action.
can be tailor-made to suit your company’s needs. Packages include to learn more visit www.iccwbo.org/bascap
complimentary entry passes, targeted marketing to industry officials Medical news Today is the largest independent medical and health news
and executives, and bespoke networking opportunities. site on the web - with over 2,500,000 unique monthly users it is ranked
number one for medical news on Google and yahoo! Medical news Today
is used by Blue Chip pharmaceutical and health organizations, advertising
Other features of sponsorship include: agencies, PR companies and vertical ad networks to deliver targeted
disease/condition and general health campaigns.
• Prominent exhibition space in the main conference for more information contact peter@medicalnewstoday.com or visit
networking area www.medicalnewstoday.com.
• Participation in comprehensive pre-event marketing campaigns Adis journals not only offer independent, high-quality content with
• Tailored marketing strategies to suit your organisation’s size, enviable impact factors; they also provide an unparalleled evaluation
of the available evidence on new and established pharmacological
capabilities and individual requirements interventions. Covering all aspects of the drug development continuum
from bench-to-bedside, Adis journals are a unique must-have resource
for researchers, clinicians, clinical pharmacists and pharmacologists,
For more information and to discuss the right teachers, students, and anyone with an interest in independent reviews
opportunity, contact Michael Adeniya on and original research needed to support better therapeutic decisions.
Adis journals offer the most comprehensive and objective, evidence-based
+44 (0)207 368 9300 or enquire@iqpc.co.uk information on: • Clinical pharmacology • Health economics and outcomes
• Pharmacovigilance • Biotechnology and personalized medicine –
adisonline.com
International Pharmaceutical Industry (IPI) IPI was established to fill in the
void for effective marketing and communication between all stakeholders
Featured Exhibitor in the life sciences sector globally. Clients use us due to the extensive
knowledge and reach we have built up over the years with our Editor,
Editorial Advisory board and market research. We give you links into all
areas of Biopharm, Medical, Pharmaceutical and Healthcare. In addition
to our extensive reach in the Americas & Europe, we have established a
strong presence in the Middle East, Latin America, Eastern Europe, Asia
and Africa which are becoming increasingly important to the way the
industry is moving forwards in areas of Research and Development, Trials,
manufacturing and Technology Transfer. www.ipimedia.com
Journal for Clinical Studies – Published bi-monthly, JCS is a unique
journal, dedicated to providing information to the global pharmaceutical,
The Leading Life Science Logistics Specialists. biotechnology, medical devices and CROs, practical and theoretical
operational procedures, challenges, validatory and regulatory guidelines
Founded in 1980, Marken is focused on supporting the premium when conducting trials on a multisite basis and particularly within the
logistics of pharmaceutical, biotechnology and clinical service emerging markets, naïve patient population, and remote access areas.
We give you country by country objectives on all disease study areas, but
companies. Through our strategically placed offices we manage uniquely bring you experiences in developing country diseases such as
Liver diseases, kidney diseases, insect borne diseases, malnutrition and
the collection, transport of specimens and distribution of under nutrition. Led by a strong editorial advisory board sourced out for
temperature sensitive clinical trial supplies. Additionally through their experiences, you will get the most practical insight for your global
studies. So join us, write for us, feature your experiences with us, advertise
our depot network we support the storage and distribution of your capabilities with us, and ask our advisory board for suggestions and
life science assets. Our team members and network of facilities guidelines. Let us make health care available to all. www.jforcs.com
bridge the distance between patients and the essential resources Swiss Biotech Association (SBA) was founded in March 1998. Today over
of life science companies. 200 companies represent this growing association. SBA is the industry
association of small- and medium-sized enterprises active in all areas
Marken understands the specialised and dynamic needs of our of biotechnology as well as a very good networking platform for the
multinational companies active in the sector. The membership is open to
industry; we retain our global agility by continuously investing companies of various size concerned with different aspects of modern
in our people, technologies and global installations to better biotechnology such as R&D, production, marketing and sales, finance,
services and consulting. Activities of member companies span different
support our clients. sectors of biotechnology including (bio-)pharmaceuticals, diagnostics,
agriculture, food, environmental biotechnology, nanotech, nutrition,
People marine-oriented research and specialty chemicals.www.swissbiotech.org
With over 400 people in 25 offices spanning the world, Pharmatching.com is an efficient, targeted and easy-to-use-“Web2.0”-tool
Marken has the expertise to ship globally and deliver locally to for finding the right partners in the pharmaceutical industry worldwide.
It saves time and costs in all (out)sourcing and business development
investigator sites or directly to patients. processes, as it facilitates and accelerates the searching process for
appropriate business partners significantly.
Technologies Pharmatching.com is particularly advantageous for projects where a
Our state of the art management, tracking and information special service is (immediately) required or to offer capacities which are
currently available. It is useful for services in all categories and stages of
systems are second to none offering our clients real time drug development including contract manufacturing, contract research,
visibility to the last mile. From hand to hand our chain of custody laboratory investigations, contractual testing, non-clinical and clinical
research, active pharmaceutical ingredients, consulting, marketing,
reflects our dedication to supporting and exceeding our client's registration, in- and outlicensing etc.
expectations. BioM Biotech Cluster Development GmbH serves as the coordinating
agency of the Munich Biotech Cluster, and is the top address for all
The combination of expertise, agility, and resources are biotechnology companies and start-ups in the region. The MunichBiotech
complemented by our dedication to supporting our clients, their Cluster is a constantly growing hotbed of innovation. The Greater Munich
Area counts over 20,000 persons employed by more than 350 companies
patients and the many lives that depend on our services. in the life science sector (Biotech, Pharma, CRO, Suppliers) – plus more
than 10,000 scientist in world renowned institutions like Max-Planck, the
www.marken.com universitie LMU and TUM - making Munich one of the top regions in Europe.
Munich has won a governmental grant in combination with substantial
commitment from industry running now a €100 Mio-program in
“personalized medicine”: www.bio-m.org/en
W W W.G L O B A L C L I n I C A L O U T S O U R C I n G .C O M
+44 (0)20 7368 9300 +44 (0)20 7368 9301 enquire@iqpc.co.uk

6. 5 Ways to Register
Freephone: 0800 652 2363 or
Location: +44 (0)20 7368 9300
THE WESTIn GRAnD, MUnICH
two Day conference:
17TH – 18TH MAy 2011
Pre-conference workshoP Day: Fax: +44 (0)20 7368 9301
16TH MAy 2011
post: your booking form to
IQPC
To speed registration, please provide the priority code located on the mailing label or in the box below.
Customer Services
My registration code PDFW 129 Wilton Road
Victoria, London
Please contact our database manager on +44(0) 207 368 9300 or database@iqpc.co.uk quoting the SW1 V1JZ
registration code above to inform us of any changes or to remove your details.
enquire@iqpc.co.uk
Register now for as little as €549! email:
stanDarD sUPPLier rates www.globalclinicaloutsourcing.com
Packages register and pay register and pay register and pay standard
by 25th feb* by 25th Mar* by 29th april* Price
team Discounts*
conference + 2 workshops + full saVe €500 saVe €450 saVe €350 €3747 + VAT
access to conference recordings €3247 + VAT €3297 + VAT €3397 + VAT Teams of 3 receive 10% off, Teams of 5 receive 15% off, Teams of 7 receive 20%
conference + 1 workshop + full saVe €400 saVe €350 saVe €250 off Team discounts are only available on standard pricing packages and there is only
€3098 + VAT
access to conference recordings** €2698 + VAT €2748 + VAT €2848 + VAT one discount available per person booking at the same time from the same company
saVe €200 saVe €150
conference only €1899 + VAT €1899 + VAT
audio recordings
€1699 + VAT €1749 + VAT
€550 + VAT
Venue & accommoDation
Venue: The Westin Grand, Munich, Arabellastrasse 6, 81925 München,
PharMa anD Biotech ManUfactUrer rates Germany, Tel: +49 89 9264 0, Fax: +49 89 9264 8699
Accommodation: Travel and accommodation are not included in the
Packages register and pay register and pay register and pay standard registration fee, however a number of discounted bedrooms have been
by 25th feb* by 25th Mar* by 29th april* Price
reserved at the Westin Grand Hotel. Please call the hotel directly on
conference + 2 workshops + full saVe €1898 saVe €1898 saVe €1698 Tel: + 49 89 92640 and quote booking reference IQPC to receive your
€3747 + VAT
access to conference recordings €1849 + VAT €1849 + VAT €2049 + VAT discounted rate, prices start from €159 excluding taxes and breakfast. There
conference + 1 workshop + full saVe €1649 saVe €1649 saVe €1449 is limited availability so we do encourage attendees to book early to avoid
€3098 + VAT
access to conference recordings** €1449 + VAT €1449 + VAT €1649 + VAT disappointment. For a further selection of discounted hotels please visit:
conference + full access saVe €1600 saVe €1600 saVe €1500 www.4cityhotels.com/munich.html
to conference recordings €849 + VAT €849 + VAT €949 + VAT €2449 + VAT
conference only
saVe €1350
€549 + VAT
saVe €1350
€549 + VAT
saVe €1250
€649 + VAT €1899 + VAT Free online resources
* To qualify for discounts, payments must be received by the early bird registration deadline. To claim a variety of articles, podcasts and other free resources please visit
Early booking discounts are not valid in conjunction with any other offer.
** Please select your choice of Workshop: A or the Masterclass www.globalclinicaloutsourcing.com
***Tick this box to remove conference recordings and reduce the price by 300 euros
German VAT charged at 19%. VAT Registration # DE 261 1019 14
Digital conFerence on cD-rom
Delegate Details A digital version of the conference proceedings, including all presentations,
Please photocopy for each additional delegate is available to buy.
6 Mr 6 Mrs 6 Miss 6 Ms 6 Dr 6 Other 6 I cannot attend the event, please send me the CD Rom priced at £599 plus VAT
Recent digital conferences available - £599 plus VAT each
First Name Family Name
6 Innovation in Phase I Clinical Trials
Job Title 6 Clinical Data Standardisation and Management
Tel No. 6 Innovation in Clinical Design, Analysis and Reporting
Email 6 Optimising Clinical Development in Oncology
6 Yes I would like to receive information about products and services via email 6 Optimising Clinical Development for CNS
Organisation 6 Clinically Relevant Drug Transporters
Nature of business 6 Please send me conference materials indicated above
Address 6 I have filled out credit card details opposite
Postcode Country For further information Please call: 0207 368 9300 or email: knowledgebank@iqpc.co.uk
Telephone Fax To search IQPC’s archived conference documentation visit: www.iqpcknowledgebank.com
Approving Manager
Name of person completing form if different from delegate: terms anD conDitions
Please read the information listed below as each booking is subject to IQPC Ltd standard
Signature terms and conditions. Payment Terms: Upon completion and return of the registration
form, full payment is required no later than 5 business days from the date of invoice.
I agree to IQPC’s cancellation, substitution and payment terms. Payment of invoices by means other than by credit card or purchase order (UK Plc and
UK government bodies only) will be subject to a €69 (plus VAT) per delegate processing
Special dietary requirements: 6 Vegetarian 6 Non-dairy 6 Other (please specify) fee. Payment must be received prior to the conference date. We reserve the right to refuse
Please indicate if you have already registered by Phone 6 Fax 6 Email 6 Web 6 admission to the conference if payment has not been received. IQPC Cancellation,
Postponement and Substitution Policy: You may substitute delegates at any time by
Please note: if you have not received an acknowledgement before the conference, please call us to confirm your booking. providing reasonable advance notice to IQPC. For any cancellations received in writing not
less than eight (8) days prior to the conference, you will receive a 90% credit to be used
at another IQPC conference which must occur within one year from the date of issuance of
payment methoD such credit. An administration fee of 10% of the contract fee will be retained by IQPC for all
permitted cancellations. No credit will be issued for any cancellations occurring within seven
Total price for your Organisation: (Add total of all individuals attending): (7) days (inclusive) of the conference. In the event that IQPC cancels an event for any reason,
conFerence coDe 18514.002
you will receive a credit for 100% of the contract fee paid. You may use this credit for another
IQPC event to be mutually agreed with IQPC, which must occur within one year from the date
Card Number: VISA 6 M/C 6 AMEX 6 of cancellation. In the event that IQPC postpones an event for any reason and the delegate
6666666666666666 is unable or unwilling to attend in on the rescheduled date, you will receive a credit for
100% of the contract fee paid. You may use this credit for another IQPC event to be mutually
agreed with IQPC, which must occur within one year from the date of postponement. Except
Exp. Date: 6 6 6 6 Sec: 6 6 6 6 as specified above, no credits will be issued for cancellations. There are no refunds given
under any circumstances. IQPC is not responsible for any loss or damage as a result of a
substitution, alteration or cancellation/postponement of an event. IQPC shall assume no
Name On Card: Signature: liability whatsoever in the event this conference is cancelled, rescheduled or postponed
due to a fortuitous event, Act of God, unforeseen occurrence or any other event that renders
Billing Address (if different from below): performance of this conference impracticable, illegal or impossible. For purposes of this
clause, a fortuitous event shall include, but not be limited to: war, fire, labour strike, extreme
weather or other emergency. Please note that while speakers and topics were confirmed at
City/County/Postcode Cheque enclosed for: € (Made payable to IQPC Ltd.) the time of publishing, circumstances beyond the control of the organizers may necessitate
substitutions, alterations or cancellations of the speakers and/or topics. As such, IQPC
reserves the right to alter or modify the advertised speakers and/or topics if necessary
(Please quote 18514.002 with remittance advice) without any liability to you whatsoever. Any substitutions or alterations will be updated on our
web page as soon as possible. Discounts: All ‘Early Bird’ Discounts require payment at time
IQPC Bank details: HSBC Bank Plc, 67 George Street, Richmond, Surrey, TW9 1HG, United Kingdom of registration and before the cut-off date in order to receive any discount.
Any discounts offered by IQPC (including Team Discounts) require payment at the time of
Sort Code: 40 05 15 Account No: 59090618 IBAN Code: GB98 MIDL 4005 1559 0906 18 registration. Discount offers cannot be combined with any other offer.
Swift Code: MIDLGB22 Account name: International Quality & Productivity Centre Ltd
payment must Be receiVeD prior to the conFerence